Home › Funds › GreatBanc Trust CO › ABT

GreatBanc Trust CO position in ABT

ABBOTT LABORATORIES · Health Care

GreatBanc Trust CO reported holding 3,580 shares of ABT (ABBOTT LABORATORIES) in its Q3 2026 13F filing — a position valued at US$354K, representing 0.21% of its reported portfolio and ranking #47 among its reported holdings. GreatBanc Trust CO has disclosed ABT holdings in 5 of the last 5 reported quarters, going back to Q3 2025.

Latest position (Q3 2026)3.58K sh
Reported value held$353.81K
Portfolio Weight0.21%
First reportedQ3 2025
Last changeAdd
Updated2026-11-04

Last updated: 2026-11-04 · Source: SEC EDGAR Form 13F-HR

How GreatBanc Trust CO's ABT position evolved

GreatBanc Trust CO first disclosed a stake in ABT in Q3 2025 at 3,665 shares (US$491K). Across 5 filings, GreatBanc Trust CO increased the stake 2 time(s), trimmed it 1 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 3,580 shares valued at US$354K — an increase of 120 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2025 3.67K $490.89K New
Q4 2025 3.67K $459.19K Hold
Q1 2026 3.79K $389.12K Add
Q2 2026 3.46K $313.96K Reduce
Q3 2026 3.58K $353.81K Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABT and 13F data

ABT (ABBOTT LABORATORIES) is a Health Care company. 20 other funds we track also report a position in ABT — the largest reported positions include Vanguard Group (US$22.00B), Charles Schwab Investment Management (US$5.41B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$5.41B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABT

All ABT fund holders →

FAQ

How long has GreatBanc Trust CO held ABT?

GreatBanc Trust CO has disclosed ABT holdings in 5 of the last 5 reported quarters, going back to Q3 2025.

What is GreatBanc Trust CO's current position in ABT?

As of Q3 2026, GreatBanc Trust CO holds 3.58K shares of ABT (ABBOTT LABORATORIES), valued at $353.81K, representing 0.21% of its reported portfolio and ranking #47.

Has GreatBanc Trust CO been buying or selling ABT?

In the latest 13F filing (Q3 2026), GreatBanc Trust CO increased its position in ABT.

Which other funds hold ABT?

Other major institutional holders of ABT include Vanguard Group, Charles Schwab Investment Management, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, among 20 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.